HCPCS Codes Similar to Q0249

HCPCS Codes Similar to “Q0249” Code.
Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg

M0235 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	M0236 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON
M0237 Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON	M0238 Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON
M0249 Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose Code added date: 20210624 Code effective date: 20210624 TXT \| PDF \| XML \| JSON	M0250 Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose Code added date: 20210624 Code effective date: 20210624 TXT \| PDF \| XML \| JSON
Q0235 Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	Q0237 Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON
A4483 Moisture exchanger, disposable, for use with invasive mechanical ventilation Code added date: 19990101 Code effective date: 20030101 TXT \| PDF \| XML \| JSON	E0550 Humidifier, durable for extensive supplemental humidification during ippb treatments or oxygen delivery Code added date: 19860101 Code effective date: 20050701 TXT \| PDF \| XML \| JSON
E0560 Humidifier, durable for supplemental humidification during ippb treatment or oxygen delivery Code added date: 19860101 Code effective date: 20050701 TXT \| PDF \| XML \| JSON	J3262 Injection, tocilizumab, 1 mg Code added date: 20110101 Code effective date: 20110101 TXT \| PDF \| XML \| JSON
Q5133 Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg Code added date: 20240401 Code effective date: 20241001 TXT \| PDF \| XML \| JSON	Q5135 Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg Code added date: 20241001 Code effective date: 20241001 TXT \| PDF \| XML \| JSON

M0235 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	M0236 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON
M0237 Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON	M0238 Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON
M0249 Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose Code added date: 20210624 Code effective date: 20210624 TXT \| PDF \| XML \| JSON	M0250 Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose Code added date: 20210624 Code effective date: 20210624 TXT \| PDF \| XML \| JSON
Q0235 Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	Q0237 Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON
A4483 Moisture exchanger, disposable, for use with invasive mechanical ventilation Code added date: 19990101 Code effective date: 20030101 TXT \| PDF \| XML \| JSON	E0550 Humidifier, durable for extensive supplemental humidification during ippb treatments or oxygen delivery Code added date: 19860101 Code effective date: 20050701 TXT \| PDF \| XML \| JSON
E0560 Humidifier, durable for supplemental humidification during ippb treatment or oxygen delivery Code added date: 19860101 Code effective date: 20050701 TXT \| PDF \| XML \| JSON	J3262 Injection, tocilizumab, 1 mg Code added date: 20110101 Code effective date: 20110101 TXT \| PDF \| XML \| JSON
Q5133 Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg Code added date: 20240401 Code effective date: 20241001 TXT \| PDF \| XML \| JSON	Q5135 Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg Code added date: 20241001 Code effective date: 20241001 TXT \| PDF \| XML \| JSON